FindTrial
Sign In

Esaxerenone

3 trials

Sponsors

Wada Jun, Tsujita Kenichi, Kumamoto University

Conditions

Hypertensive Patients with Left Ventricular Hypertrophy Hypertensive Patients with Left Ventricular HypertrophyHypertensive patients with diabetic kidney disease DKD, HypertensionType 2 diabetes mellitus with hypertension

Unknown Phase

EX-DKD study
Active, not recruitingJPRN-jRCTs061190027
Wada JunHypertensive patients with diabetic kidney disease DKD, Hypertension
Start: 2020-02-25Target: 120Updated: 2026-06-29
ESES-LVH study
Active, not recruitingJPRN-jRCTs071190043
Tsujita KenichiHypertensive Patients with Left Ventricular Hypertrophy Hypertensive Patients with Left Ventricular Hypertrophy
Start: 2020-06-26Target: 120Updated: 2026-06-29
Effect of Esaxerenone, a novel mineralocorticoid receptor antagonist on insulin resistance in diabetic patients with hypertension.
Active, not recruitingJPRN-UMIN000041326
Kumamoto UniversityType 2 diabetes mellitus with hypertension
Start: 2020-09-01Target: 10Updated: 2026-06-29

Related Papers

Efficacy and Safety of Esaxerenone in Hypertensive Patients with Left Ventricular Hypertrophy (ESES-LVH) Study: A Multicenter, Open-Label, Prospective, Interventional Study.
2024-02-0416 citations
S-17-5: EFFECT OF MINERALOCORTICOID RECEPTOR BLOCKER, ESAXERENONE, ON HOME BLOOD PRESSURE AND ALBUMINURIA IN JAPANESE HYPERTENSIVE PATIENTS WITH DKD (EX-DKD STUDY)
Journal of Hypertension2023-01-01
PS-P15-9: EFFECT OF MINERALOCORTICOID RECEPTOR BLOCKER, ESAXERENONE, ON HOME BLOOD PRESSURE AND CARDIAC HYPERTROPHY IN HYPERTENSIVE PATIENTS WITH LVH (ESES-LVH STUDY)
Journal of Hypertension2023-01-01
Efficacy and Safety of Esaxerenone in Hypertensive Patients with Diabetic Kidney Disease: A Multicenter, Open-Label, Prospective Study.
2022-09-0730 citations